(Q67898756)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Methimazole treatment aggravates low-dose streptozotocin-induced diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

3 December 2022

author name string

T. Hibbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826876

3 December 2022

U. Kiesel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826876

3 December 2022

V. Kolb-Bachofen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826876

3 December 2022

H. Kolb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826876

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1826876

3 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:016882279190141Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

https://api.elsevier.com/content/article/PII:016882279190141Y?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Diabetes Research and Clinical Practice

3 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

53-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppressive effects of antithyroid drugs

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Immunoregulation in autoimmune thyroid disease

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Effect of the anti-thyroid drug methimazole on interleukin-1 and interleukin-2 levels in vitro

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Effects of methimazole on human lymphocyte proliferation and natural killer cell activity

3 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Methimazole blocks Graves' IgG but not interferon-gamma HLA-DR expression by thyroid cells

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Inhibition of NK cell-induced cytolysis by thiocarbamide antithyroid drugs

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Effects of methimazole on human lymphocyte proliferation and natural killer cell activity

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

The accumulation of [35S]methimazole by monocytes and macrophages

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression.

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

The immunosuppressive effect of methimazole on cell-mediated immunity is mediated by its capacity to inhibit peroxidase and to scavenge free oxygen radicals

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Oxygen free radical scavengers protect rat islet cells from damage by cytokines

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Effects of radical scavengers on the development of experimental diabetes

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia.

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Mac-1: a macrophage differentiation antigen identified by monoclonal antibody

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

The Effect of Methimazole on the Development of Spontaneous Lymphocytic Thyroiditis in the Diabetes-Prone BB/W Rat

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Effect of iodine intake and methimazole on lymphocytic thyroiditis in the BB/W rat

3 December 2022

25

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1

3 December 2022

26

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

The antithyroid arthritis syndrome reviewed

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

A “collagen-like” syndrome associated with antithyroid therapy

3 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Arthritis induced by antithyroid medication

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Polymyositis after propylthiouracil treatment for hyperthyroidism

3 December 2022

31

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Methimazole-induced arthritis

3 December 2022

32

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats

3 December 2022

33

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

Immunostimulation circumvents diabetes in NOD/Lt mice

3 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/0168-8227(91)90141-Y

3 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1826876%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference